Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Alving

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Comprehensive Therapy|July 21, 1998
Update on recognition and management of patients with acquired or inherited hypercoagulabilityB Alving
Transfusion|December 5, 1998
Potential for synthetic phospholipids as partial platelet substitutesB Alving
Reviews of Infectious Diseases|May 1, 1989
Effect of dengue virus on procoagulant and fibrinolytic activities of monocytesC Krishnamurti, B Alving
Archives of Pathology & Laboratory Medicine|June 26, 1999
How to improve transfusion medicine. A treating physician's perspectiveB Alving, K Alcorn
Annals of Internal Medicine|May 15, 1997
Response to activated protein C and cerebrovascular diseaseM P Jones, B Alving
Current Opinion in Hematology|September 1, 1996
Laboratory testing for hypercoagulable disordersM P Jones, B Alving
Surgery|June 1, 1997
Postoperative bleeding induced by topical bovine thrombin: report of two casesR J Christie, L Carrington, B Alving
Seminars in Thrombosis and Hemostasis|December 5, 1998
Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapyJ K Waselenko, M C Nace, B Alving
Thrombosis and Haemostasis|March 1, 1997
Variation in test results for APC resistance with factor V deficient plasma from different donorsM P Jones, L Carrington, M Cutting, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1989
Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery diseaseA Oseroff, C Krishnamurti, A Hassett, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Comprehensive Therapy|July 21, 1998
Update on recognition and management of patients with acquired or inherited hypercoagulabilityB Alving
Transfusion|December 5, 1998
Potential for synthetic phospholipids as partial platelet substitutesB Alving
Reviews of Infectious Diseases|May 1, 1989
Effect of dengue virus on procoagulant and fibrinolytic activities of monocytesC Krishnamurti, B Alving
Archives of Pathology & Laboratory Medicine|June 26, 1999
How to improve transfusion medicine. A treating physician's perspectiveB Alving, K Alcorn
Annals of Internal Medicine|May 15, 1997
Response to activated protein C and cerebrovascular diseaseM P Jones, B Alving
Current Opinion in Hematology|September 1, 1996
Laboratory testing for hypercoagulable disordersM P Jones, B Alving
Surgery|June 1, 1997
Postoperative bleeding induced by topical bovine thrombin: report of two casesR J Christie, L Carrington, B Alving
Seminars in Thrombosis and Hemostasis|December 5, 1998
Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapyJ K Waselenko, M C Nace, B Alving
Thrombosis and Haemostasis|March 1, 1997
Variation in test results for APC resistance with factor V deficient plasma from different donorsM P Jones, L Carrington, M Cutting, et al.
The Journal of Laboratory and Clinical Medicine|January 1, 1989
Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery diseaseA Oseroff, C Krishnamurti, A Hassett, et al.
Pageof 2